Masimo Corp.'s appeals in an ongoing electrocardiogram patent case were largely rejected by the US Patent and Trademark Office’s Patent and Trial and Appeal Board (PTAB) on 12 September.
In May 2022, the PTAB ruled in favor of Apple Inc. in an inter partes review of eight...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?